COVID-19 UPDATES: Click here to read more!
Click here to get on our COVID-19 Waiting List

Get Healthy!

  • Posted May 13, 2026

GLP-1 Drugs Linked To Better Breast Cancer Outcomes

In a new study, breast cancer patients using GLP-1 medications for obesity and/or diabetes had a lower risk of recurrence and death over 10 years of follow-up.

Health News is provided as a service to Seip Drug site users by HealthDay. Seip Drug nor its employees, agents, or contractors, review, control, or take responsibility for the content of these articles. Please seek medical advice directly from your pharmacist or physician.
Copyright © 2026 HealthDay All Rights Reserved.